Phase II Hedgehog Inhibitor for Myelodysplastic Syndrome (MDS)

Clinical trial NCT01842646 · COMPLETED

Trial details

NCT number: NCT01842646
Sponsor: H. Lee Moffitt Cancer Center and Research Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Myelodysplastic Syndrome (MDS)Chronic Myelomonocytic Leukemia (CMML)

Start date: 2013-08-29
Primary completion: 2016-01-31
Enrollment: 35

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.